ArticleJournal of clinical medicine2025
The Prognostic Roles of Systemic Inflammatory Markers Before Abiraterone or Enzalutamide Therapy in Metastatic Castration-Resistant Prostate Cancer.
Harun Muğlu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.